Search filters

List of works by Massimiliano Castellazzi

25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis

scientific article published on 6 October 2009

Altered miRNA expression in T regulatory cells in course of multiple sclerosis

scientific article

Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders

scientific article published in October 2001

Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer's disease and mild cognitive impairment

scientific article published on 27 December 2019

Autophagy and mitophagy elements are increased in body fluids of multiple sclerosis-affected individuals

scientific article published on 2 September 2017

Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy

scientific article published in March 2004

Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker

scientific article published on 18 December 2012

CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis

scientific article published on 21 January 2008

Cerebrospinal fluid analysis and the determination of oligoclonal bands.

scientific article published in October 2017

Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.

scientific article published in June 2006

Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis

scientific article published on August 2004

Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms.

scientific article published on September 2009

Chlamydophila pneumoniae DNA and mRNA transcript levels in peripheral blood mononuclear cells and cerebrospinal fluid of patients with multiple sclerosis.

scientific article published on 20 May 2008

Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules

scientific article published in December 2002

Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.

scientific article

Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.

scientific article

Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis

scientific article

Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients

scientific article published on 27 June 2019

Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases

scientific article published on 13 June 2016

Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis.

scientific article

Effects of anticoagulants on the activity of gelatinases.

scientific article published on 24 August 2007

Emerging topics and new perspectives on HLA-G.

scientific article

Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.

scientific article published on 26 May 2015

Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.

scientific article published on 18 May 2010

Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.

scientific article

Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients.

scientific article published on 13 April 2017

Evidence of cerebrospinal fluid free kappa light chains in AIDS patients with Toxoplasma gondii encephalitis

scientific article published on 01 August 2000

Incidence study of Guillain-Barré syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up

scientific article published on 07 January 2019

Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients

scientific article published on 10 September 2019

Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study

scientific article published in January 2007

Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy

scientific article

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients

scientific article published on 31 July 2016

Intrathecal levels of vitamin D and IgG in multiple sclerosis

scientific article published on 23 July 2011

Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms.

scientific article published on February 2004

Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation

scientific article published on 28 April 2013

Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis

scientific article published in February 2006

Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosis

scientific article published on 15 June 2010

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

scientific article published on 08 May 2019

Matrix Metalloproteinases as a Pleiotropic Biomarker in Medicine and Biology.

scientific article published on 9 November 2016

Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.

scientific article published on 5 June 2013

Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms

scientific article published on 17 February 2012

Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies

scientific article published on 09 February 2007

Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies

scientific article published on 01 June 2007

Molecular detection of Parachlamydia-like organisms in cerebrospinal fluid of patients with multiple sclerosis

scientific article published on May 2008

Molecular identification and antibody testing of Chlamydophila pneumoniae in a subgroup of patients with HIV-associated dementia complex. Preliminary results

scientific article published on March 2003

Multiple Sclerosis in Italy: A 40-Year Follow-Up of the Prevalence in Ferrara

scientific article published on 21 August 2018

Neurofilament ELISA validation

scientific article published on 24 October 2009

Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis

scientific article published on 24 March 2009

Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis

scientific article published on 6 August 2009

Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings

scientific article published in September 2003

Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis

scientific article published on 22 August 2012

Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.

scientific article published on 02 June 2016

Sexual dimorphism in the cerebrospinal fluid total protein content

scientific article published on 29 June 2020

Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis

scientific article

Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis

scientific article published on 7 November 2007

Specific antibodies reacting to JC polyomavirus capsid protein mimotopes in sera from multiple sclerosis and other neurological diseases-affected patients

scientific article published on 03 February 2020

Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis

scientific article